ES2992389T3 - Procedimiento y aparato para determinar la información de dosis de medicamento - Google Patents

Procedimiento y aparato para determinar la información de dosis de medicamento Download PDF

Info

Publication number
ES2992389T3
ES2992389T3 ES19200742T ES19200742T ES2992389T3 ES 2992389 T3 ES2992389 T3 ES 2992389T3 ES 19200742 T ES19200742 T ES 19200742T ES 19200742 T ES19200742 T ES 19200742T ES 2992389 T3 ES2992389 T3 ES 2992389T3
Authority
ES
Spain
Prior art keywords
analyte
user
processor
data
insulin
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
ES19200742T
Other languages
English (en)
Spanish (es)
Inventor
Marc Barry Taub
Erwin Satrya Budiman
Jai Karan
Timothy Christian Dunn
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Abbott Diabetes Care Inc
Original Assignee
Abbott Diabetes Care Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Abbott Diabetes Care Inc filed Critical Abbott Diabetes Care Inc
Application granted granted Critical
Publication of ES2992389T3 publication Critical patent/ES2992389T3/es
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00—Measuring for diagnostic purposes; Identification of persons
    • A61B5/48—Other medical applications
    • A61B5/4836—Diagnosis combined with treatment in closed-loop systems or methods
    • A61B5/4839—Diagnosis combined with treatment in closed-loop systems or methods combined with drug delivery
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00—Measuring for diagnostic purposes; Identification of persons
    • A61B5/145—Measuring characteristics of blood in vivo, e.g. gas concentration or pH-value ; Measuring characteristics of body fluids or tissues, e.g. interstitial fluid or cerebral tissue
    • A61B5/14532—Measuring characteristics of blood in vivo, e.g. gas concentration or pH-value ; Measuring characteristics of body fluids or tissues, e.g. interstitial fluid or cerebral tissue for measuring glucose, e.g. by tissue impedance measurement
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00—Measuring for diagnostic purposes; Identification of persons
    • A61B5/72—Signal processing specially adapted for physiological signals or for diagnostic purposes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00—Measuring for diagnostic purposes; Identification of persons
    • A61B5/72—Signal processing specially adapted for physiological signals or for diagnostic purposes
    • A61B5/7271—Specific aspects of physiological measurement analysis
    • A61B5/7275—Determining trends in physiological measurement data; Predicting development of a medical condition based on physiological measurements, e.g. determining a risk factor
    • G—PHYSICS
    • G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16H—HEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA
    • G16H20/00—ICT specially adapted for therapies or health-improving plans, e.g. for handling prescriptions, for steering therapy or for monitoring patient compliance
    • G16H20/10—ICT specially adapted for therapies or health-improving plans, e.g. for handling prescriptions, for steering therapy or for monitoring patient compliance relating to drugs or medications, e.g. for ensuring correct administration to patients
    • G16H20/17—ICT specially adapted for therapies or health-improving plans, e.g. for handling prescriptions, for steering therapy or for monitoring patient compliance relating to drugs or medications, e.g. for ensuring correct administration to patients delivered via infusion or injection
    • G—PHYSICS
    • G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16H—HEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA
    • G16H40/00—ICT specially adapted for the management or administration of healthcare resources or facilities; ICT specially adapted for the management or operation of medical equipment or devices
    • G16H40/60—ICT specially adapted for the management or administration of healthcare resources or facilities; ICT specially adapted for the management or operation of medical equipment or devices for the operation of medical equipment or devices
    • G16H40/63—ICT specially adapted for the management or administration of healthcare resources or facilities; ICT specially adapted for the management or operation of medical equipment or devices for the operation of medical equipment or devices for local operation
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00—Measuring for diagnostic purposes; Identification of persons
    • A61B5/145—Measuring characteristics of blood in vivo, e.g. gas concentration or pH-value ; Measuring characteristics of body fluids or tissues, e.g. interstitial fluid or cerebral tissue
    • A61B5/14507—Measuring characteristics of blood in vivo, e.g. gas concentration or pH-value ; Measuring characteristics of body fluids or tissues, e.g. interstitial fluid or cerebral tissue specially adapted for measuring characteristics of body fluids other than blood
    • A61B5/1451—Measuring characteristics of blood in vivo, e.g. gas concentration or pH-value ; Measuring characteristics of body fluids or tissues, e.g. interstitial fluid or cerebral tissue specially adapted for measuring characteristics of body fluids other than blood for interstitial fluid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00—Measuring for diagnostic purposes; Identification of persons
    • A61B5/145—Measuring characteristics of blood in vivo, e.g. gas concentration or pH-value ; Measuring characteristics of body fluids or tissues, e.g. interstitial fluid or cerebral tissue
    • A61B5/1495—Calibrating or testing of in-vivo probes
    • G—PHYSICS
    • G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16H—HEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA
    • G16H50/00—ICT specially adapted for medical diagnosis, medical simulation or medical data mining; ICT specially adapted for detecting, monitoring or modelling epidemics or pandemics
    • G16H50/30—ICT specially adapted for medical diagnosis, medical simulation or medical data mining; ICT specially adapted for detecting, monitoring or modelling epidemics or pandemics for calculating health indices; for individual health risk assessment

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medical Informatics (AREA)
  • Biomedical Technology (AREA)
  • Physics & Mathematics (AREA)
  • Biophysics (AREA)
  • Veterinary Medicine (AREA)
  • Pathology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Molecular Biology (AREA)
  • Surgery (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Primary Health Care (AREA)
  • Artificial Intelligence (AREA)
  • Computer Vision & Pattern Recognition (AREA)
  • Signal Processing (AREA)
  • Psychiatry (AREA)
  • Physiology (AREA)
  • Optics & Photonics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Emergency Medicine (AREA)
  • Business, Economics & Management (AREA)
  • General Business, Economics & Management (AREA)
  • Measurement Of The Respiration, Hearing Ability, Form, And Blood Characteristics Of Living Organisms (AREA)
  • Measuring And Recording Apparatus For Diagnosis (AREA)
  • Infusion, Injection, And Reservoir Apparatuses (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
ES19200742T 2011-12-30 2012-12-29 Procedimiento y aparato para determinar la información de dosis de medicamento Active ES2992389T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US201161582209P 2011-12-30 2011-12-30

Publications (1)

Publication Number Publication Date
ES2992389T3 true ES2992389T3 (es) 2024-12-11

Family

ID=48698675

Family Applications (1)

Application Number Title Priority Date Filing Date
ES19200742T Active ES2992389T3 (es) 2011-12-30 2012-12-29 Procedimiento y aparato para determinar la información de dosis de medicamento

Country Status (10)

Country Link
US (2) US20130184547A1 (enExample)
EP (3) EP4249034A3 (enExample)
JP (1) JP6479475B2 (enExample)
AU (6) AU2012362155A1 (enExample)
CA (2) CA3280159A1 (enExample)
DK (1) DK3662965T3 (enExample)
ES (1) ES2992389T3 (enExample)
FI (1) FI3662965T3 (enExample)
LT (1) LT3662965T (enExample)
WO (1) WO2013102158A1 (enExample)

Families Citing this family (62)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20190357827A1 (en) 2003-08-01 2019-11-28 Dexcom, Inc. Analyte sensor
US7697967B2 (en) 2005-12-28 2010-04-13 Abbott Diabetes Care Inc. Method and apparatus for providing analyte sensor insertion
US9788771B2 (en) 2006-10-23 2017-10-17 Abbott Diabetes Care Inc. Variable speed sensor insertion devices and methods of use
US11298058B2 (en) 2005-12-28 2022-04-12 Abbott Diabetes Care Inc. Method and apparatus for providing analyte sensor insertion
US9675290B2 (en) 2012-10-30 2017-06-13 Abbott Diabetes Care Inc. Sensitivity calibration of in vivo sensors used to measure analyte concentration
US8140312B2 (en) 2007-05-14 2012-03-20 Abbott Diabetes Care Inc. Method and system for determining analyte levels
AU2007308804A1 (en) 2006-10-26 2008-05-02 Abbott Diabetes Care, Inc. Method, system and computer program product for real-time detection of sensitivity decline in analyte sensors
CA2683962C (en) 2007-04-14 2017-06-06 Abbott Diabetes Care Inc. Method and apparatus for providing data processing and control in medical communication system
US8591410B2 (en) 2008-05-30 2013-11-26 Abbott Diabetes Care Inc. Method and apparatus for providing glycemic control
US8103456B2 (en) 2009-01-29 2012-01-24 Abbott Diabetes Care Inc. Method and device for early signal attenuation detection using blood glucose measurements
US20100198034A1 (en) 2009-02-03 2010-08-05 Abbott Diabetes Care Inc. Compact On-Body Physiological Monitoring Devices and Methods Thereof
EP4434458A3 (en) 2010-03-24 2024-12-18 Abbott Diabetes Care, Inc. Medical device inserters
US10092229B2 (en) 2010-06-29 2018-10-09 Abbott Diabetes Care Inc. Calibration of analyte measurement system
US10136845B2 (en) 2011-02-28 2018-11-27 Abbott Diabetes Care Inc. Devices, systems, and methods associated with analyte monitoring devices and devices incorporating the same
US20120265036A1 (en) 2011-04-15 2012-10-18 Dexcom, Inc. Advanced analyte sensor calibration and error detection
WO2013066849A1 (en) 2011-10-31 2013-05-10 Abbott Diabetes Care Inc. Model based variable risk false glucose threshold alarm prevention mechanism
US8710993B2 (en) 2011-11-23 2014-04-29 Abbott Diabetes Care Inc. Mitigating single point failure of devices in an analyte monitoring system and methods thereof
DK3831283T3 (da) 2011-12-11 2023-05-30 Abbott Diabetes Care Inc Analytsensorindretninger, forbindelser og fremgangsmåder
EP2890297B1 (en) 2012-08-30 2018-04-11 Abbott Diabetes Care, Inc. Dropout detection in continuous analyte monitoring data during data excursions
WO2014052136A1 (en) 2012-09-26 2014-04-03 Abbott Diabetes Care Inc. Method and apparatus for improving lag correction during in vivo measurement of analyte concentration with analyte concentration variability and range data
US10433773B1 (en) 2013-03-15 2019-10-08 Abbott Diabetes Care Inc. Noise rejection methods and apparatus for sparsely sampled analyte sensor data
US9474475B1 (en) 2013-03-15 2016-10-25 Abbott Diabetes Care Inc. Multi-rate analyte sensor data collection with sample rate configurable signal processing
WO2014152034A1 (en) 2013-03-15 2014-09-25 Abbott Diabetes Care Inc. Sensor fault detection using analyte sensor data pattern comparison
AU2014374361B9 (en) 2013-12-31 2019-07-04 Abbott Diabetes Care Inc. Self-powered analyte sensor and devices using the same
EP3125761B1 (en) 2014-03-30 2020-09-30 Abbott Diabetes Care Inc. Method and apparatus for determining meal start and peak events in analyte monitoring systems
US9459089B2 (en) * 2014-04-09 2016-10-04 Qualcomm Incorporated Method, devices and systems for detecting an attachment of an electronic patch
EP3050504B1 (en) * 2014-10-22 2020-06-17 Glutalor Medical Inc Continuous glucose monitoring system and monitoring terminal
EP3294134B1 (en) 2015-05-14 2020-07-08 Abbott Diabetes Care Inc. Inserter system for a compact medical device and corresponding method
US10213139B2 (en) 2015-05-14 2019-02-26 Abbott Diabetes Care Inc. Systems, devices, and methods for assembling an applicator and sensor control device
CA2991716C (en) 2015-07-10 2026-05-12 Abbott Diabetes Care Inc. System, device and method of dynamic glucose profile response to physiological parameters
CN105193426B (zh) * 2015-11-05 2016-08-17 山东大数据医疗科技有限公司 无创式血糖仪
CN105496373A (zh) * 2016-01-02 2016-04-20 无锡桑尼安科技有限公司 智能化医疗辅助系统
WO2018064222A1 (en) * 2016-09-27 2018-04-05 Bigfoot Biomedical, Inc. Medicine injection and disease management systems, devices, and methods
AU2017376111B2 (en) 2016-12-12 2023-02-02 Bigfoot Biomedical, Inc. Alarms and alerts for medication delivery devices and related systems and methods
EP4716273A3 (en) 2016-12-20 2026-06-17 Abbott Diabetes Care Inc. Systems, devices and methods for wireless communications in analyte monitoring devices
EP3570735A4 (en) 2017-01-23 2020-10-21 Abbott Diabetes Care Inc. SYSTEMS, DEVICES AND METHODS FOR INSERTING ANALYTE SENSOR
EP3600014B1 (en) 2017-03-21 2025-07-30 Abbott Diabetes Care Inc. Devices and system for providing diabetic condition diagnosis
US11331022B2 (en) 2017-10-24 2022-05-17 Dexcom, Inc. Pre-connected analyte sensors
CN111246797B (zh) 2017-10-24 2025-09-09 德克斯康公司 预连接分析物传感器
US10987464B2 (en) 2017-12-12 2021-04-27 Bigfoot Biomedical, Inc. Pen cap for insulin injection pens and associated methods and systems
US11464459B2 (en) 2017-12-12 2022-10-11 Bigfoot Biomedical, Inc. User interface for diabetes management systems including flash glucose monitor
AU2018383731B2 (en) * 2017-12-12 2024-11-07 Bigfoot Biomedical, Inc. Therapy management systems, methods, and devices
US11116899B2 (en) 2017-12-12 2021-09-14 Bigfoot Biomedical, Inc. User interface for diabetes management systems and devices
US11077243B2 (en) 2017-12-12 2021-08-03 Bigfoot Biomedical, Inc. Devices, systems, and methods for estimating active medication from injections
US11197964B2 (en) 2017-12-12 2021-12-14 Bigfoot Biomedical, Inc. Pen cap for medication injection pen having temperature sensor
US11083852B2 (en) 2017-12-12 2021-08-10 Bigfoot Biomedical, Inc. Insulin injection assistance systems, methods, and devices
USD911355S1 (en) 2018-03-29 2021-02-23 Bigfoot Biomedical, Inc. Display screen or portion thereof with graphical user interface
USD928199S1 (en) 2018-04-02 2021-08-17 Bigfoot Biomedical, Inc. Medication delivery device with icons
EP4585143A3 (en) 2018-06-07 2025-10-01 Abbott Diabetes Care, Inc. Focused sterilization and sterilized sub-assemblies for analyte monitoring systems
US12205699B1 (en) 2018-10-30 2025-01-21 Bigfoot Biomedical, Inc. Method of pairing therapy devices using shared secrets, and related systems, methods and devices
MX2021007294A (es) 2018-12-21 2021-07-15 Abbott Diabetes Care Inc Sistemas, dispositivos y metodos para la insercion de sensores de analito.
CA3123936A1 (en) * 2019-01-04 2020-07-09 Abbott Diabetes Care Inc. Systems, devices, and methods for improved meal and therapy interfaces in analyte monitoring systems
US10998091B2 (en) * 2019-02-07 2021-05-04 Sandeep Patil Systems for monitoring compliance with a patch dosage regimen and methods of using the same
CN113811951A (zh) * 2019-02-21 2021-12-17 康帕宁医疗公司 用于药物剂量计算器的方法、系统和装置
US11776684B2 (en) 2019-09-26 2023-10-03 Pacesetter, Inc Method and device for managing energy usage by a medical device
US20210151190A1 (en) 2019-11-15 2021-05-20 Dexcom, Inc. Joint state estimation prediction that evaluates differences in predicted vs. corresponding received data
MY192294A (en) 2020-08-31 2022-08-17 Abbott Diabetes Care Inc Systems, devices, and methods for analyte sensor insertion
EP4413917B1 (en) 2020-09-15 2025-12-03 Abbott Diabetes Care Inc. Systems, devices, and methods for analyte monitoring
CA3186905A1 (en) 2020-09-15 2022-03-24 Abbott Diabetes Care Inc. Systems, devices, and methods for an analyte sensor
US12667674B2 (en) 2020-10-02 2026-06-30 Bigfoot Biomedical, Inc. Injection site determination systems and methods for injection site tracking and recommending injection sites
EP4370029A1 (en) 2021-07-16 2024-05-22 Abbott Diabetes Care Inc. Systems, devices, and methods for analyte monitoring
US12702332B2 (en) 2022-01-04 2026-08-11 Abbott Diabetes Care Inc. Systems, devices, and methods for analyte monitoring

Family Cites Families (43)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5264104A (en) 1989-08-02 1993-11-23 Gregg Brian A Enzyme electrodes
US5262035A (en) 1989-08-02 1993-11-16 E. Heller And Company Enzyme electrodes
US5593852A (en) 1993-12-02 1997-01-14 Heller; Adam Subcutaneous glucose electrode
US5262305A (en) 1991-03-04 1993-11-16 E. Heller & Company Interferant eliminating biosensors
US5320715A (en) 1994-01-14 1994-06-14 Lloyd Berg Separation of 1-pentanol from cyclopentanol by extractive distillation
DE29711371U1 (de) 1997-06-30 1997-11-27 Siemens AG, 80333 München Vorrichtung zur Verbindung von Leiterplatten getrennter Geräte
US8974386B2 (en) * 1998-04-30 2015-03-10 Abbott Diabetes Care Inc. Analyte monitoring device and methods of use
US6175752B1 (en) 1998-04-30 2001-01-16 Therasense, Inc. Analyte monitoring device and methods of use
US6036508A (en) 1998-12-21 2000-03-14 Hamilton Sundstrand Corporation Connector for interconnecting a bus bar to a circuit board
US7806886B2 (en) * 1999-06-03 2010-10-05 Medtronic Minimed, Inc. Apparatus and method for controlling insulin infusion with state variable feedback
WO2001088524A1 (en) 2000-05-12 2001-11-22 Therasense, Inc. Electrodes with multilayer membranes and methods of using and making the electrodes
ES2304394T3 (es) * 2000-08-18 2008-10-16 Animas Technologies Llc Dispositivo para la prediccion de eventos hipoglucemicos.
US20030208113A1 (en) * 2001-07-18 2003-11-06 Mault James R Closed loop glycemic index system
US6544212B2 (en) * 2001-07-31 2003-04-08 Roche Diagnostics Corporation Diabetes management system
JP2003084101A (ja) 2001-09-17 2003-03-19 Dainippon Printing Co Ltd 光学素子用樹脂組成物、光学素子、およびプロジェクションスクリーン
US8010174B2 (en) * 2003-08-22 2011-08-30 Dexcom, Inc. Systems and methods for replacing signal artifacts in a glucose sensor data stream
US7299082B2 (en) 2003-10-31 2007-11-20 Abbott Diabetes Care, Inc. Method of calibrating an analyte-measurement device, and associated methods, devices and systems
EP2316331B1 (en) * 2003-12-09 2016-06-29 Dexcom, Inc. Signal processing for continuous analyte sensor
US7291107B2 (en) * 2004-08-26 2007-11-06 Roche Diagnostics Operations, Inc. Insulin bolus recommendation system
US7869851B2 (en) * 2004-12-23 2011-01-11 Roche Diagnostics Operations, Inc. System and method for determining insulin bolus quantities
US7547281B2 (en) * 2005-02-01 2009-06-16 Medtronic Minimed, Inc. Algorithm sensor augmented bolus estimator for semi-closed loop infusion system
KR100638727B1 (ko) 2005-02-28 2006-10-30 삼성전기주식회사 Ｚｉｇｂｅｅ 및 불루투스 겸용 송수신기
US8473022B2 (en) * 2008-01-31 2013-06-25 Abbott Diabetes Care Inc. Analyte sensor with time lag compensation
US7630748B2 (en) 2006-10-25 2009-12-08 Abbott Diabetes Care Inc. Method and system for providing analyte monitoring
US7946985B2 (en) * 2006-12-29 2011-05-24 Medtronic Minimed, Inc. Method and system for providing sensor redundancy
US20080228056A1 (en) * 2007-03-13 2008-09-18 Michael Blomquist Basal rate testing using frequent blood glucose input
US20100145262A1 (en) * 2007-05-03 2010-06-10 Novo Nordisk A/S Safety system for insulin delivery advisory algorithms
US10002233B2 (en) * 2007-05-14 2018-06-19 Abbott Diabetes Care Inc. Method and apparatus for providing data processing and control in a medical communication system
US8417311B2 (en) * 2008-09-12 2013-04-09 Optiscan Biomedical Corporation Fluid component analysis system and method for glucose monitoring and control
US7751907B2 (en) * 2007-05-24 2010-07-06 Smiths Medical Asd, Inc. Expert system for insulin pump therapy
US8444595B2 (en) * 2007-06-15 2013-05-21 Animas Corporation Methods to pair a medical device and at least a remote controller for such medical device
US20090143725A1 (en) * 2007-08-31 2009-06-04 Abbott Diabetes Care, Inc. Method of Optimizing Efficacy of Therapeutic Agent
EP4159114B1 (en) * 2007-10-09 2024-04-10 DexCom, Inc. Integrated insulin delivery system with continuous glucose sensor
US8377031B2 (en) * 2007-10-23 2013-02-19 Abbott Diabetes Care Inc. Closed loop control system with safety parameters and methods
US20090240127A1 (en) * 2008-03-20 2009-09-24 Lifescan, Inc. Methods of determining pre or post meal time slots or intervals in diabetes management
US8924159B2 (en) * 2008-05-30 2014-12-30 Abbott Diabetes Care Inc. Method and apparatus for providing glycemic control
CA2675227C (en) * 2008-08-15 2017-09-05 Lifescan Scotland Limited Analyte testing method and system
US8734422B2 (en) * 2008-08-31 2014-05-27 Abbott Diabetes Care Inc. Closed loop control with improved alarm functions
EP3881874A1 (en) * 2008-09-15 2021-09-22 DEKA Products Limited Partnership Systems and methods for fluid delivery
US20100198034A1 (en) 2009-02-03 2010-08-05 Abbott Diabetes Care Inc. Compact On-Body Physiological Monitoring Devices and Methods Thereof
US20100298685A1 (en) * 2009-05-22 2010-11-25 Abbott Diabetes Care Inc. Adaptive insulin delivery system
US8762070B2 (en) * 2010-02-11 2014-06-24 Regents Of The University Of California Systems, devices and methods to deliver biological factors or drugs to a subject
US8579879B2 (en) * 2010-02-19 2013-11-12 Medtronic Minimed, Inc. Closed-loop glucose control startup

Also Published As

Publication number Publication date
JP6479475B2 (ja) 2019-03-06
AU2024202384B2 (en) 2025-12-18
EP2797660A4 (en) 2015-08-19
US20130184547A1 (en) 2013-07-18
JP2015505264A (ja) 2015-02-19
CA2840644A1 (en) 2013-07-04
US20190192071A1 (en) 2019-06-27
EP3662965A1 (en) 2020-06-10
WO2013102158A1 (en) 2013-07-04
AU2024202384A1 (en) 2024-05-02
EP4249034A2 (en) 2023-09-27
AU2026202005A1 (en) 2026-04-02
EP4249034A3 (en) 2023-11-15
AU2019201453B2 (en) 2021-08-12
DK3662965T3 (da) 2024-07-22
AU2019201453A1 (en) 2019-03-21
AU2012362155A1 (en) 2014-01-23
CA3280159A1 (en) 2026-03-02
EP2797660B1 (en) 2019-10-02
AU2021266271A1 (en) 2021-12-09
EP3662965B1 (en) 2024-05-01
EP2797660A1 (en) 2014-11-05
AU2017228654A1 (en) 2017-10-05
LT3662965T (lt) 2024-08-12
AU2021266271B2 (en) 2024-01-11
FI3662965T3 (fi) 2024-07-10

Similar Documents

Publication Publication Date Title
AU2024202384B2 (en) Method and apparatus for determining medication dose information
US12364419B2 (en) Mitigating single point failure of devices in an analyte monitoring system and methods thereof
US12254978B2 (en) Compatibility mechanisms for devices in a continuous analyte monitoring system and methods thereof
US10952653B2 (en) Methods and systems for early signal attenuation detection and processing
AU2025271139A1 (en) Systems, devices, and methods for improved meal and therapy interfaces in analyte monitoring systems